Discover the Company’s Promise of Support™ Program at Booth #818
Maple Grove, MN – April 12, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will be participating in the 2024 American Academy of ... Read More
Acquisition expands Bora’s North American footprint with first US manufacturing site Taipei, Taiwan, April 1st, 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that it has successfully completed the ... Read More
Maple Grove, MN – March 29, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced the recent launch of Methimazole Tablets, USP, 5 mg and 10 mg. The Methimazole Tablet market had U.S. sales of approximately ... Read More
Maple Grove, MN – February 6, 2024 – Upsher-Smith Laboratories, LLC (Upsher-Smith) and the National Alliance of State Pharmacy Associations (NASPA) proudly announce the recipients of the 2023 NASPA Excellence in Innovation Award. This annual ... Read More
Osaka, Japan – January 17, 2024 – Sawai Group Holdings Co., Ltd. (Sawai Group, Head office: Osaka, Japan, President: Mitsuo Sawai) announced that its Board of Directors, at a meeting held on January 16, resolved ... Read More
Taipei, Taiwan, January 16th, 2024 – Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), today announced that its Board of Directors has approved the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics manufacturer ... Read More
For many Americans, getting a generic medicine involves a simple trip to a local pharmacy or a quick check of their mailbox. But for people who really know the industry, the picture is more complicated—and, ... Read More
